SEPSF (ASEP Medical Holdings) FCF Margin %: -98.11% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SEPSF ASEP Medical Holdings Inc SEPSF
19 GF Score
Price $0.01
! 4 Warning Signs
View Full Analysis

What is ASEP Medical Holdings FCF Margin %?

ASEP Medical Holdings SEPSF 19 FCF Margin % is -98.11% as of Mar. 2026. GuruFocus rates SEPSF with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 950 Biotechnology companies, ASEP Medical Holdings ranks worse than 64.74% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ASEP Medical Holdings's Free Cash Flow for the three months ended in Mar. 2026 was $-0.05 Mil. ASEP Medical Holdings's Revenue for the three months ended in Mar. 2026 was $0.05 Mil. Therefore, ASEP Medical Holdings's FCF Margin % for the quarter that ended in Mar. 2026 was -98.11%.

As of today, ASEP Medical Holdings's current FCF Yield % is -49.27%.

The historical rank and industry rank for ASEP Medical Holdings's FCF Margin % or its related term are showing as below:

SEPSF' s FCF Margin % Range Over the Past 10 Years
Min: -12938.1   Med: -361.42   Max: -113.09
Current: -302.05

During the past 5 years, the highest FCF Margin % of ASEP Medical Holdings was -113.09%. The lowest was -12938.10%. And the median was -361.42%.

SEPSF's FCF Margin % is ranked worse than
64.74% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs SEPSF: -302.05

ASEP Medical Holdings FCF Margin % Related Terms

ASEP Medical Holdings FCF Margin % Historical Data

* Premium members only.

The historical data trend for ASEP Medical Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings FCF Margin % Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 0.00 -12,656.25 -113.40 -361.89

ASEP Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.00 -277.78 -779.63 -137.35 -98.11

SEPSF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, ASEP Medical Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASEP Medical Holdings FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's FCF Margin % falls into.


SEPSF
19GF Score
ASEP Medical Holdings Inc SEPSF
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASEP Medical Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ASEP Medical Holdings's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.883/0.244
=-361.89 %

ASEP Medical Holdings's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.052/0.053
=-98.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -98.11% mean?
ASEP Medical Holdings (SEPSF) has a FCF Margin % of -98.11% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ASEP Medical Holdings and its competitors. According to the industry distribution chart, ASEP Medical Holdings ranks #615 out of 950 companies in the Biotechnology industry, placing it in the top 64.7%.
Is ASEP Medical Holdings' FCF Margin % too high?
ASEP Medical Holdings' current FCF Margin % is -98.11%. Based on the distribution chart, ASEP Medical Holdings ranks #615 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, ASEP Medical Holdings has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #615 out of 950 companies for FCF Margin %. This places ASEP Medical Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ASEP Medical Holdings and its competitors. ASEP Medical Holdings's current FCF Margin % is -98.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (SEPSF) has a current FCF Margin % of -98.11%. The current FCF Margin % is -98.11%. ASEP Medical Holdings' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For ASEP Medical Holdings (SEPSF), the current FCF Margin % is -98.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASEP Medical Holdings Business Description

Other Exchanges JJ80:GermanyASEP:Canada
Address 4400 Chatterton Way, Unit 202, Victoria, BC, CAN, V8X 5J2
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
19GF Score

Get the complete analysis for SEPSF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price